Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Tonsillar Hypertrophy: later-stage trial registry
2 of 5 indexed Tonsillar Hypertrophy trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Tonsillar Hypertrophy: 5 US clinical trials tracked, 2 recruiting.
Tonsillar Hypertrophy is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Loma Linda University, running 1 of these trials.
Enrollment posture brief
Registry condition tonsillar-hypertrophy
OPEN 2 | RECR 40% | LATE 3 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)
Tonsillar Hypertrophy lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Tonsillar Hypertrophy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Tonsillar Hypertrophy is recruiting below its size-band peers.
2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Tonsillar Hypertrophy research.
Loma Linda University accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Most Tonsillar Hypertrophy trials plan to enrol fewer than 100 people.
Median target enrolment is 84 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
Tonsillar Hypertrophy research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Optimization of Pediatric Tonsillectomy to IMprove AnaLgesia
Duke University
NCT06576830
Lateral Pharyngoplasty Outcomes in Children Undergoing Tonsillectomy
Loma Linda University
NCT05575401
Metabolomic Profiling of Racial Disparity
Nationwide Children's Hospital
NCT06266429
Lidocaine Infusion for Pain Relief in Children Scheduled for Tonsillectomy and Adenoidectomy
Rhode Island Hospital
NCT03902314
Management of Post-Tonsillectomy Pain in Pediatric Patients
Washington University School of Medicine
NCT04551196
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Tonsillar Hypertrophy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Tonsillar Hypertrophy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Tonsillar Hypertrophy page
5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Tonsillar Hypertrophy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Loma Linda University sponsors the most Tonsillar Hypertrophy trials on record, review their full trial history before evaluating a specific study. See Loma Linda University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tonsillar Hypertrophy condition card totals 5 registered trials; most-linked intervention Combined Acetaminophen and Ibuprofen; top US site state Rhode Island. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.